The prevalence of PTEN mutations in a clinical pediatric cohort with autism spectrum disorders, developmental delay, and macrocephaly.
paper
Cited
Public
Unavailable
- Authors
- Varga, Elizabeth A; Pastore, Matthew; Prior, Thomas; Herman, Gail E; McBride, Kim L
- Year
- 2009
- Journal
- Genetics in medicine : official journal of the American College of Medical Genetics
- PMID
- 19265751
- DOI
- 10.1097/GIM.0b013e31818fd762
PURPOSE: To define the prevalence of PTEN mutations in a clinical cohort of pediatric subjects with autism spectrum disorders (ASDs), developmental delay/mental retardation (DD/MR), and/or macrocephaly and to assess genotype-phenotype correlations. METHODS: Medical records of patients who had clinical PTEN gene sequencing ordered through our institution between January 1, 2005 and December 31, 2007 were abstracted to confirm genetic test results and medical diagnoses. Phenotypic information related to the diagnoses, prenatal history, early developmental milestones, physical characteristics, and family history for those with a confirmed PTEN mutation was also recorded. RESULTS: One hundred fourteen patients were tested during this time period for indications of ASDs (N = 60), DD/MR (N = 49), or macrocephaly only (N = 5). Eleven mutations were identified: five in patients with ASDs and six in those with DD/MR, resulting in a prevalence of 8.3% and 12.2% in these respective clinical populations. All individuals with a PTEN mutation had significant macrocephaly (>2.0 SD) CONCLUSIONS: These data illustrate that PTEN gene sequencing has a high diagnostic yield when performed in a selected population of individuals with ASDs or DD/MR and macrocephaly. Germline mutations in PTEN are an important, identifiable etiology among these patients.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| A genome-wide scan for common alleles affecting risk for autism. | 2010 | 20663923 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Altered Expression of MeCP2 and PTEN Genes in the Molecular Basis of Specific Learning Disorder. | Atasever F et al. | β | 2025 | β |
| Characterizing Developmental and Behavioral Profiles in Developmental Synaptopathies to Inform Clinical Trial Endpoints. | Valluripalli Soorya L et al. | β | 2025 | β |
| Defective Neural Stem and Progenitor Cell Proliferation in Neurodevelopmental Disorders. | Shigenaka A et al. | β | 2025 | β |
| Epilepsy and Developmental Delay in Pediatric Patients With PTEN Variants and a Literature Review. | Li Q et al. | β | 2025 | β |
| Genetically encoded biosensor for fluorescence lifetime imaging of PTEN dynamics in the intact brain. | Kagan T et al. | β | 2025 | β |
| Genomic diversity in functionally relevant genes modifies neurodevelopmental versus neoplastic risks in individuals with germline PTEN variants. | Kim AY et al. | β | 2025 | β |
| Mechanisms of brain overgrowth in autism spectrum disorder with macrocephaly. | Currey L et al. | β | 2025 | β |
| Phenotypic rescue via mTOR inhibition in neuron-specific Pten knockout mice reveals AKT and mTORC1-site specific changes. | D'Amore A et al. | β | 2025 | β |
| PTEN in somatostatin neurons regulates fear and anxiety and is required for inhibitory synaptic connectivity within central amygdala. | Holford TW et al. | β | 2025 | β |
| PTEN mutations impair CSF dynamics and cortical networks by dysregulating periventricular neural progenitors. | DeSpenza T et al. | β | 2025 | β |
| Cerebellar phenotypes in germline PTEN mutation carriers. | Gambini D et al. | β | 2024 | β |
| Clinical Neurologic Features and Evaluation of PTEN Hamartoma Tumor Syndrome: A Systematic Review. | Dhawan A et al. | β | 2024 | β |
| Developmental trajectory and sex differences in auditory processing in a PTEN-deletion model of autism spectrum disorders. | Croom K et al. | β | 2024 | β |
| Female-specific dysfunction of sensory neocortical circuits in a mouse model of autism mediated by mGluR5 and estrogen receptor Ξ±. | Molinaro G et al. | β | 2024 | β |
| <i>C. elegans</i>: a prominent platform for modeling and drug screening in neurological disorders. | Romussi S et al. | β | 2024 | β |
| Quantitative evaluation of DNA damage repair dynamics to elucidate predictors of autism vs. cancer in individuals with germline PTEN variants. | Wei R et al. | β | 2024 | β |
| Therapeutic role of PTEN in tissue regeneration for management of neurological disorders: stem cell behaviors to an in-depth review. | Li Y et al. | β | 2024 | β |
| A neural stem cell paradigm of pediatric hydrocephalus. | Duy PQ et al. | β | 2023 | β |
| A potent and selective CXCR2 antagonist improves neuroimmune dysregulation through the inhibition of NF-ΞΊB and notch inflammatory signaling in the BTBR mouse model of autism. | Alomar HA et al. | β | 2023 | β |
| Endophenotype trait domains for advancing gene discovery in autism spectrum disorder. | Mosconi MW et al. | β | 2023 | β |
| mTOR Signaling Disruption and Its Association with the Development of Autism Spectrum Disorder. | Thomas SD et al. | β | 2023 | β |
| The mitochondrial genome as a modifier of autism versus cancer phenotypes in <i>PTEN</i> hamartoma tumor syndrome. | Wei R et al. | β | 2023 | β |
| A Comprehensive Study of De Novo Mutations on the Protein-Protein Interaction Interfaces Provides New Insights into Developmental Delay. | Maharjan DT et al. | β | 2022 | β |
| Autism-associated CHD8 keeps proliferation of human neural progenitors in check by lengthening the G1 phase of the cell cycle. | Coakley-Youngs E et al. | β | 2022 | β |
| Behavioural and psychological features of PTEN mutations: a systematic review of the literature and meta-analysis of the prevalence of autism spectrum disorder characteristics. | Cummings K et al. | β | 2022 | β |
| Considerations on diagnosis and surveillance measures of PTEN hamartoma tumor syndrome: clinical and genetic study in a series of Spanish patients. | Pena-Couso L et al. | β | 2022 | β |
| Genetic and Environmental Contributions to Autism Spectrum Disorder Through Mechanistic Target of Rapamycin. | Sato A et al. | β | 2022 | β |
| Genetic Testing in Patients with Neurodevelopmental Disorders: Experience of 511 Patients at Cincinnati Children's Hospital Medical Center. | Du X et al. | β | 2022 | β |
| Genotype-phenotype associations in a large PTEN Hamartoma Tumor Syndrome (PHTS) patient cohort. | Hendricks LAJ et al. | β | 2022 | β |
| <i>Pten</i> haploinsufficiency causes desynchronized growth of brain areas involved in sensory processing. | Clipperton-Allen AE et al. | β | 2022 | β |
| Loss of PTEN phosphorylation via single point mutation alters cortical connectivity and behaviour. | Binder M et al. | β | 2022 | β |
| MicroRNA and MicroRNA-Target Variants Associated with Autism Spectrum Disorder and Related Disorders. | Wong A et al. | β | 2022 | β |
| Neuroblastoma and cutaneous angiosarcoma in a child with PTEN hamartoma tumor syndrome. | Leibowitz MS et al. | β | 2022 | β |
| Novel deletion of exon 3 in TYRΒ gene causing Oculocutaneous albinism 1B in an Indian family along with intellectual disability associated with chromosomal copy number variations. | Dhangar S et al. | β | 2022 | β |
| PTEN hamartoma tumor syndrome in childhood and adolescence-a comprehensive review and presentation of the German pediatric guideline. | Plamper M et al. | β | 2022 | β |
| Re-emerging concepts of immune dysregulation in autism spectrum disorders. | Erbescu A et al. | β | 2022 | β |
| Sex Differences in Autism Spectrum Disorder: Diagnostic, Neurobiological, and Behavioral Features. | Napolitano A et al. | β | 2022 | β |
| The Cerebellar Involvement in Autism Spectrum Disorders: From the Social Brain to Mouse Models. | Mapelli L et al. | β | 2022 | β |
| Validation of a computational phenotype for finding patients eligible for genetic testing for pathogenic PTEN variants across three centers. | Kothari C et al. | β | 2022 | β |
| A systematic review of brain MRI findings in monogenic disorders strongly associated with autism spectrum disorder. | Frewer V et al. | β | 2021 | β |
| Autism-associated CHD8 keeps proliferation of human neural progenitors in check by lengthening the G1 phase of the cell cycle | Coakley-Youngs E et al. | β | 2021 | β |
| Conditional Pten knockout in parvalbumin- or somatostatin-positive neurons sufficiently leads to autism-related behavioral phenotypes. | Shin S et al. | β | 2021 | β |
| Cross-level analysis of molecular and neurobehavioral function in a prospective series of patients with germline heterozygous PTEN mutations with and without autism. | Frazier TW et al. | β | 2021 | β |
| Current Approaches and Future Directions for the Treatment of mTORopathies. | Karalis V et al. | β | 2021 | β |
| Cytoplasmic-predominant Pten increases microglial activation and synaptic pruning in a murine model with autism-like phenotype. | Sarn N et al. | β | 2021 | β |
| Distinguishing between PTEN clinical phenotypes through mutation analysis. | Portelli S et al. | β | 2021 | β |
| Dopaminergic Dysregulation in Syndromic Autism Spectrum Disorders: Insights From Genetic Mouse Models. | Kosillo P et al. | β | 2021 | β |
| Environmental Enrichment Rescues Social Behavioral Deficits and Synaptic Abnormalities in <i>Pten</i> Haploinsufficient Mice. | Clipperton-Allen AE et al. | β | 2021 | β |
| Fetal Megalencephaly with Cortical Dysplasia at 18 Gestational Weeks Related to Paternal UPD Mosaicism with <i>PTEN</i> Mutation. | Pooh RK et al. | β | 2021 | β |
| Germline nuclear-predominant Pten murine model exhibits impaired social and perseverative behavior, microglial activation, and increased oxytocinergic activity. | Sarn N et al. | β | 2021 | β |
| Molecular Pathways within Autism Spectrum Disorder Endophenotypes. | Briuglia S et al. | β | 2021 | β |
| Prevalence and clinical/molecular characteristics of PTEN mutations in Turkish children with autism spectrum disorders and macrocephaly. | Kaymakcalan H et al. | β | 2021 | β |
| Proximal variants in CCND2 associated with microcephaly, short stature, and developmental delay: A case series and review of inverse brain growth phenotypes. | Pirozzi F et al. | β | 2021 | β |
| PTEN Hamartoma Syndrome in a Child Presenting With Malrotation, Panintestinal Polyps, Severe Anemia, and Protein-Losing Enteropathy. | Stoecklein N et al. | β | 2021 | β |
| PTEN mutations in autism spectrum disorder and congenital hydrocephalus: developmental pleiotropy and therapeutic targets. | DeSpenza T et al. | β | 2021 | β |
| Reciprocal control of translation and transcription in autism spectrum disorder. | Longo F et al. | β | 2021 | β |
| Redefining the PTEN promoter: identification of novel upstream transcription start regions. | Grencewicz DJ et al. | β | 2021 | β |
| Sulfur amino acid metabolism and related metabotypes of autism spectrum disorder: A review of biochemical evidence for a hypothesis. | Indika NR et al. | β | 2021 | β |
| Targeting PI3K-AKT/mTOR signaling in the prevention of autism. | Sharma A et al. | β | 2021 | β |
| Two Monogenetic Disorders, Activated PI3-Kinase-Ξ΄ Syndrome 2 and Smith-Magenis Syndrome, in One Patient: Case Report and a Literature Review of Neurodevelopmental Impact in Primary Immunodeficiencies Associated With Disturbed PI3K Signaling. | Moreno-Corona N et al. | β | 2021 | β |
| Autism-associated PTEN missense mutation leads to enhanced nuclear localization and neurite outgrowth in an induced pluripotent stem cell line. | Wong CW et al. | β | 2020 | β |
| Cell Adhesion Molecules Involved in Neurodevelopmental Pathways Implicated in 3p-Deletion Syndrome and Autism Spectrum Disorder. | Gandawijaya J et al. | β | 2020 | β |
| Connecting Genotype with Behavioral Phenotype in Mouse Models of Autism Associated with <i>PTEN</i> Mutations. | Clipperton-Allen AE et al. | β | 2020 | β |
| Cowden syndrome complicated by schizophrenia: A first clinical report. | Kobayashi Y et al. | β | 2020 | β |
| Evaluating the Role of MAST1 as an Intellectual Disability Disease Gene: Identification of a Novel De Novo Variant in a Patient with Developmental Disabilities. | Ben-Mahmoud A et al. | β | 2020 | β |
| Genetics and the Gynecologic Patient. | Wade KS et al. | β | 2020 | β |
| Infantile macrocephaly and multiple subcutaneous lipomas diagnosed with <i>PTEN</i> hamartoma tumor syndrome: A case report. | Yotsumoto Y et al. | β | 2020 | β |
| Neural Mechanisms Underlying Repetitive Behaviors in Rodent Models of Autism Spectrum Disorders. | Gandhi T et al. | β | 2020 | β |
| NS-Pten adult knockout mice display both quantitative and qualitative changes in urine-induced ultrasonic vocalizations. | Binder MS et al. | β | 2020 | β |
| PIK3R2/Pik3r2 Activating Mutations Result in Brain Overgrowth and EEG Changes. | Shi X et al. | β | 2020 | β |
| PTEN hamartoma tumor syndrome in children: diagnosis based on cutaneous manifestations with a focus on translucent palmoplantar papules. | Pham F et al. | β | 2020 | β |
| PTEN hamartoma tumour syndrome: what happens when there is no PTEN germline mutation? | Yehia L et al. | β | 2020 | β |
| The Clinical Spectrum of <i>PTEN</i> Mutations. | Yehia L et al. | β | 2020 | β |
| The Role of PTEN in Neurodevelopment. | Skelton PD et al. | β | 2020 | β |
| A novel missense <i>PTEN</i> mutation identified in a patient with macrocephaly and developmental delay. | Ueno Y et al. | β | 2019 | β |
| Autism Spectrum Disorder Associated with Germline Heterozygous <i>PTEN</i> Mutations. | Frazier TW | β | 2019 | β |
| Cowden Disease: Case Report and Review of the Literature. | Son JH et al. | β | 2019 | β |
| Deleterious Variation in BRSK2 Associates with a Neurodevelopmental Disorder. | Hiatt SM et al. | β | 2019 | β |
| Distinct Alterations in Tricarboxylic Acid Cycle Metabolites Associate with Cancer and Autism Phenotypes in Cowden Syndrome and Bannayan-Riley-Ruvalcaba Syndrome. | Yehia L et al. | β | 2019 | β |
| GeneAnalytics Pathways and Profiling of Shared Autism and Cancer Genes. | Gabrielli AP et al. | β | 2019 | β |
| Genetic Suppression of mTOR Rescues Synaptic and Social Behavioral Abnormalities in a Mouse Model of Pten Haploinsufficiency. | Huang WC et al. | β | 2019 | β |
| <i>PTEN</i> gene mutations in patients with macrocephaly and classic autism: A systematic review. | Zahedi Abghari F et al. | β | 2019 | β |
| <i>PTEN</i> Hamartoma Tumor Syndrome: A Clinical Overview. | Pilarski R | β | 2019 | β |
| Neurobehavioral phenotype of autism spectrum disorder associated with germline heterozygous mutations in PTEN. | Busch RM et al. | β | 2019 | β |
| Phosphoinositides: Regulators of Nervous System Function in Health and Disease. | Raghu P et al. | β | 2019 | β |
| Pten haploinsufficiency disrupts scaling across brain areas during development in mice. | Clipperton-Allen AE et al. | β | 2019 | β |
| PTEN-opathies: from biological insights to evidence-based precision medicine. | Yehia L et al. | β | 2019 | β |
| 65 YEARS OF THE DOUBLE HELIX: One gene, many endocrine and metabolic syndromes: <i>PTEN</i>-opathies and precision medicine. | Yehia L et al. | β | 2018 | β |
| A family with PTEN mutations with malignancy and an unusually high number of offspring with autism spectrum disorder: a case report. | Gruhl SL et al. | β | 2018 | β |
| A Saturation Mutagenesis Approach to Understanding PTEN Lipid Phosphatase Activity and Genotype-Phenotype Relationships. | Mighell TL et al. | β | 2018 | β |
| CRISPR-Cas9 human gene replacement and phenomic characterization in <i>Caenorhabditis elegans</i> to understand the functional conservation of human genes and decipher variants of uncertain significance. | McDiarmid TA et al. | β | 2018 | β |
| Dendritic spine anomalies and PTEN alterations in a mouse model of VPA-induced autism spectrum disorder. | Mahmood U et al. | β | 2018 | β |
| Dysregulation of the expression of HLA-DR, costimulatory molecule, and chemokine receptors on immune cells in children with autism. | Ahmad SF et al. | β | 2018 | β |
| From microcephaly to megalencephaly: determinants of brain size. | Pirozzi F et al. | β | 2018 | β |
| Imaging genetics in autism spectrum disorders: Linking genetics and brain imaging in the pursuit of the underlying neurobiological mechanisms. | Fakhoury M | β | 2018 | β |
| Macrocephaly: Solving the Diagnostic Dilemma. | Tan AP et al. | β | 2018 | β |
| Neurodevelopmental disorders in children with macrocephaly: A prevalence study and PTEN gene analysis. | Kurata H et al. | β | 2018 | β |
| Synaptopathology Involved in Autism Spectrum Disorder. | Guang S et al. | β | 2018 | β |
| A combination of genetic and biochemical analyses for the diagnosis of PI3K-AKT-mTOR pathway-associated megalencephaly. | Negishi Y et al. | β | 2017 | β |
| A retrospective chart review of the features of PTEN hamartoma tumour syndrome in children. | Hansen-Kiss E et al. | β | 2017 | β |
| Autism genetics - an overview. | Yin J et al. | β | 2017 | β |
| Cellular Phenotypes in Human iPSC-Derived Neurons from a Genetic Model of Autism Spectrum Disorder. | Deshpande A et al. | β | 2017 | β |
| Dysfunctional mTORC1 Signaling: A Convergent Mechanism between Syndromic and Nonsyndromic Forms of Autism Spectrum Disorder? | Magdalon J et al. | β | 2017 | β |
| Fundamental Elements in Autism: From Neurogenesis and Neurite Growth to Synaptic Plasticity. | Gilbert J et al. | β | 2017 | β |
| Identification of mutations in the PI3K-AKT-mTOR signalling pathway in patients with macrocephaly and developmental delay and/or autism. | Yeung KS et al. | β | 2017 | β |
| Molecular neurobiology of mTOR. | Switon K et al. | β | 2017 | β |
| Syndromic autism spectrum disorders: moving from a clinically defined to a molecularly defined approach. | Fernandez BA et al. | β | 2017 | β |
| The Pleiotropic MET Receptor Network: Circuit Development and the Neural-Medical Interface of Autism. | Eagleson KL et al. | β | 2017 | β |
| A common molecular signature in ASD gene expression: following Root 66 to autism. | Diaz-Beltran L et al. | β | 2016 | β |
| A Subset of Autism-Associated Genes Regulate the Structural Stability of Neurons. | Lin YC et al. | β | 2016 | β |
| Behavioral phenotypes of genetic mouse models of autism. | Kazdoba TM et al. | β | 2016 | β |
| Early Behavioral Abnormalities and Perinatal Alterations of PTEN/AKT Pathway in Valproic Acid Autism Model Mice. | Yang EJ et al. | β | 2016 | β |
| Increased Surface Area, but not Cortical Thickness, in a Subset of Young Boys With Autism Spectrum Disorder. | Ohta H et al. | β | 2016 | β |
| Inherited PTEN mutations and the prediction of phenotype. | Leslie NR et al. | β | 2016 | β |
| MECP2 Is a Frequently Amplified Oncogene with a Novel Epigenetic Mechanism That Mimics the Role of Activated RAS in Malignancy. | Neupane M et al. | β | 2016 | β |
| Mothers of Children with Autism have Different Rates of Cancer According to the Presence of Intellectual Disability in Their Child. | Fairthorne JC et al. | β | 2016 | β |
| mTOR, a Potential Target to Treat Autism Spectrum Disorder. | Sato A | β | 2016 | β |
| Neurotensin stimulates sortilin and mTOR in human microglia inhibitable by methoxyluteolin, a potential therapeutic target for autism. | Patel AB et al. | β | 2016 | β |
| Periventricular white matter abnormalities and restricted repetitive behavior in autism spectrum disorder. | Blackmon K et al. | β | 2016 | β |
| PI3K/AKT/mTOR-mediated autophagy in the development of autism spectrum disorder. | Zhang J et al. | β | 2016 | β |
| Prenatal Neurogenesis in Autism Spectrum Disorders. | Kaushik G et al. | β | 2016 | β |
| Superimposing Status Epilepticus on Neuron Subset-Specific PTEN Haploinsufficient and Wild Type Mice Results in Long-term Changes in Behavior. | Smith GD et al. | β | 2016 | β |
| Systematic analysis of the PTEN 5' leader identifies a major AUU initiated proteoform. | Tzani I et al. | β | 2016 | β |
| The PI3K signaling pathway as a pharmacological target in Autism related disorders and Schizophrenia. | Enriquez-Barreto L et al. | β | 2016 | β |
| Ulk4 Regulates Neural Stem Cell Pool. | Liu M et al. | β | 2016 | β |
| A method to control phosphoinositides and to analyze PTEN function in living cells using voltage sensitive phosphatases. | Mavrantoni A et al. | β | 2015 | β |
| Autism spectrum disorders: from genes to neurobiology. | Willsey AJ et al. | β | 2015 | β |
| Balancing Proliferation and Connectivity in PTEN-associated Autism Spectrum Disorder. | Tilot AK et al. | β | 2015 | β |
| Characterizing autism spectrum disorders by key biochemical pathways. | Subramanian M et al. | β | 2015 | β |
| Comorbidity of intellectual disability confounds ascertainment of autism: implications for genetic diagnosis. | Polyak A et al. | β | 2015 | β |
| Conformational stability and catalytic activity of PTEN variants linked to cancers and autism spectrum disorders. | Johnston SB et al. | β | 2015 | β |
| Cowden syndrome: recognizing and managing a not-so-rare hereditary cancer syndrome. | Mester J et al. | β | 2015 | β |
| Decreased aggression and increased repetitive behavior in Pten haploinsufficient mice. | Clipperton-Allen AE et al. | β | 2015 | β |
| Dendritic spine dysgenesis in autism related disorders. | Phillips M et al. | β | 2015 | β |
| Functionally distinct groups of inherited PTEN mutations in autism and tumour syndromes. | Spinelli L et al. | β | 2015 | β |
| Head circumference and brain size in autism spectrum disorder: A systematic review and meta-analysis. | Sacco R et al. | β | 2015 | β |
| Hereditary breast cancer syndromes and genetic testing. | Rich TA et al. | β | 2015 | β |
| Hyperactivity of newborn Pten knock-out neurons results from increased excitatory synaptic drive. | Williams MR et al. | β | 2015 | β |
| Increased CYFIP1 dosage alters cellular and dendritic morphology and dysregulates mTOR. | Oguro-Ando A et al. | β | 2015 | β |
| Molecular and phenotypic abnormalities in individuals with germline heterozygous PTEN mutations and autism. | Frazier TW et al. | β | 2015 | β |
| Neuroimaging endophenotypes in autism spectrum disorder. | Mahajan R et al. | β | 2015 | β |
| PTEN functions by recruitment to cytoplasmic vesicles. | Naguib A et al. | β | 2015 | β |
| PTEN hamartoma tumor syndrome. | Mester J et al. | β | 2015 | β |
| Pten Mutations Alter Brain Growth Trajectory and Allocation of Cell Types through Elevated Ξ²-Catenin Signaling. | Chen Y et al. | β | 2015 | β |
| Regulation of recombination and genomic maintenance. | Heyer WD | β | 2015 | β |
| The association between autism spectrum disorders and congenital anomalies by organ systems in a Finnish national birth cohort. | Timonen-Soivio L et al. | β | 2015 | β |
| Biochemical screening and PTEN mutation analysis in individuals with autism spectrum disorders and macrocephaly. | Hobert JA et al. | β | 2014 | β |
| Characteristic brain magnetic resonance imaging pattern in patients with macrocephaly and PTEN mutations. | Vanderver A et al. | β | 2014 | β |
| Deletion of PTEN produces autism-like behavioral deficits and alterations in synaptic proteins. | Lugo JN et al. | β | 2014 | β |
| Genetically meaningful phenotypic subgroups in autism spectrum disorders. | Veatch OJ et al. | β | 2014 | β |
| Genetic predisposition to colorectal cancer: where we stand and future perspectives. | Valle L | β | 2014 | β |
| Germline disruption of Pten localization causes enhanced sex-dependent social motivation and increased glial production. | Tilot AK et al. | β | 2014 | β |
| Increased risk of very low birth weight, rapid postnatal growth, and autism in underweight and obese mothers. | Moss BG et al. | β | 2014 | β |
| Maternal inflammation contributes to brain overgrowth and autism-associated behaviors through altered redox signaling in stem and progenitor cells. | Le Belle JE et al. | β | 2014 | β |
| mTOR: its role in the nervous system and involvement in neurologic disease. | Child ND et al. | β | 2014 | β |
| Neurobiology of autism gene products: towards pathogenesis and drug targets. | Kleijer KT et al. | β | 2014 | β |
| PTEN: A master regulator of neuronal structure, function, and plasticity. | Garcia-Junco-Clemente P et al. | β | 2014 | β |
| Pten haploinsufficient mice show broad brain overgrowth but selective impairments in autism-relevant behavioral tests. | Clipperton-Allen AE et al. | β | 2014 | β |
| PTEN knockdown alters dendritic spine/protrusion morphology, not density. | Haws ME et al. | β | 2014 | β |
| Subcellular targeting and dynamic regulation of PTEN: implications for neuronal cells and neurological disorders. | Kreis P et al. | β | 2014 | β |
| The neurology of mTOR. | Lipton JO et al. | β | 2014 | β |
| The social brain network and autism. | Misra V | β | 2014 | β |
| Autism genetics. | Persico AM et al. | β | 2013 | β |
| Autism spectrum disorder in the genetics clinic: a review. | Carter MT et al. | β | 2013 | β |
| Autism spectrum disorders: the quest for genetic syndromes. | Zafeiriou DI et al. | β | 2013 | β |
| Clinical neurogenetics: autism spectrum disorders. | Mehta SQ et al. | β | 2013 | β |
| Cowden syndrome and the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteria. | Pilarski R et al. | β | 2013 | β |
| Cytokine dysregulation in autism spectrum disorders (ASD): possible role of the environment. | Goines PE et al. | β | 2013 | β |
| Dysregulation of synaptic plasticity precedes appearance of morphological defects in a Pten conditional knockout mouse model of autism. | Takeuchi K et al. | β | 2013 | β |
| Head circumferences in twins with and without Autism Spectrum Disorders. | Froehlich W et al. | β | 2013 | β |
| Novel PTEN germline mutation in a family with mild phenotype: difficulties in genetic counseling. | Busa T et al. | β | 2013 | β |
| Overexpression of calcium-activated potassium channels underlies cortical dysfunction in a model of PTEN-associated autism. | Garcia-Junco-Clemente P et al. | β | 2013 | β |
| Role of the PTEN signaling pathway in autism spectrum disorder. | Lv JW et al. | β | 2013 | β |
| Toxicity of the flame-retardant BDE-49 on brain mitochondria and neuronal progenitor striatal cells enhanced by a PTEN-deficient background. | Napoli E et al. | β | 2013 | β |
| When overgrowth bumps into cancer: the PTEN-opathies. | Mester J et al. | β | 2013 | β |
| Exon-level array CGH in a large clinical cohort demonstrates increased sensitivity of diagnostic testing for Mendelian disorders. | Aradhya S et al. | β | 2012 | β |
| Genetic testing by cancer site: uterus. | Daniels MS | β | 2012 | β |
| Increased rate of amygdala growth in children aged 2 to 4 years with autism spectrum disorders: a longitudinal study. | Nordahl CW et al. | β | 2012 | β |
| Mitochondrial dysfunction in Pten haplo-insufficient mice with social deficits and repetitive behavior: interplay between Pten and p53. | Napoli E et al. | β | 2012 | β |
| Neurobiological basis of autism. | Silver WG et al. | β | 2012 | β |
| Phosphatase and tensin homolog (PTEN) gene mutations and autism: literature review and a case report of a patient with Cowden syndrome, autistic disorder, and epilepsy. | Conti S et al. | β | 2012 | β |
| Plasticity and mTOR: towards restoration of impaired synaptic plasticity in mTOR-related neurogenetic disorders. | Gipson TT et al. | β | 2012 | β |
| Pten deletion in adult hippocampal neural stem/progenitor cells causes cellular abnormalities and alters neurogenesis. | Amiri A et al. | β | 2012 | β |
| PTEN signaling in autism spectrum disorders. | Zhou J et al. | β | 2012 | β |
| The Emerging Role of microRNAs in Schizophrenia and Autism Spectrum Disorders. | Mellios N et al. | β | 2012 | β |
| The Role of PTEN in Tumor Angiogenesis. | Rodriguez S et al. | β | 2012 | β |
| Updates in the genetic evaluation of the child with global developmental delay or intellectual disability. | Flore LA et al. | β | 2012 | β |
| Working up autism: the practical role of medical genetics. | Gurrieri F | β | 2012 | β |
| A comprehensive functional analysis of PTEN mutations: implications in tumor- and autism-related syndromes. | RodrΓguez-Escudero I et al. | β | 2011 | β |
| Analysis of prevalence and degree of macrocephaly in patients with germline PTEN mutations and of brain weight in Pten knock-in murine model. | Mester JL et al. | β | 2011 | β |
| Autism and cancer risk. | Crespi B | β | 2011 | β |
| Bridging the gap between MRI and postmortem research in autism. | Schumann CM et al. | β | 2011 | β |
| Contactin 4 as an autism susceptibility locus. | Cottrell CE et al. | β | 2011 | β |
| Early generalized overgrowth in boys with autism. | Chawarska K et al. | β | 2011 | β |
| Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting. | Betancur C | β | 2011 | β |
| Frontal-subcortical protein expression following prenatal exposure to maternal inflammation. | Deng MY et al. | β | 2011 | β |
| Genetic risk in autism: new associations and clinical testing. | Freitag CM | β | 2011 | β |
| Genetic testing for autism spectrum disorders. | Bauer SC et al. | β | 2011 | β |
| Israeli children with autism spectrum disorder are not macrocephalic. | Davidovitch M et al. | β | 2011 | β |
| Mouse models of autism: testing hypotheses about molecular mechanisms. | Roullet FI et al. | β | 2011 | β |
| Ontogeny and regulation of the serotonin transporter: providing insights into human disorders. | Daws LC et al. | β | 2011 | β |
| The NeuroDevNet Autism Spectrum Disorders Demonstration Project. | Zwaigenbaum L et al. | β | 2011 | β |
| A genome-wide scan for common alleles affecting risk for autism. | Anney R et al. | β | 2010 | β |
| Cancer and Lhermitte-Duclos disease are common in Cowden syndrome patients. | Riegert-Johnson DL et al. | β | 2010 | β |
| Clinical genetic testing for patients with autism spectrum disorders. | Shen Y et al. | β | 2010 | β |
| Communication, interventions, and scientific advances in autism: a commentary. | Llaneza DC et al. | β | 2010 | β |
| Confirmation study of PTEN mutations among individuals with autism or developmental delays/mental retardation and macrocephaly. | McBride KL et al. | β | 2010 | β |
| Dermatological features of inherited cancer syndromes in adults. | Al Fares A et al. | β | 2010 | β |
| Genetics of autistic disorders: review and clinical implications. | Freitag CM et al. | β | 2010 | β |
| Mendelian genetics of rare--and not so rare--cancers. | Eng C | β | 2010 | β |
| Similarities in features of autism and asthma and a possible link to acetaminophen use. | Becker KG et al. | β | 2010 | β |
| From human tissue to animal models: Insights into the pathogenesis of cortical dysplasia. | D'Arcangelo G | β | 2009 | β |
| Gene expression profiling of lymphoblasts from autistic and nonaffected sib pairs: altered pathways in neuronal development and steroid biosynthesis. | Hu VW et al. | β | 2009 | β |
| Medical conditions in autism spectrum disorders. | Bolton PF | β | 2009 | β |